// App-Quantinova.ai

P011 : New insights into the pathogenic potential and signalling network of NKG2D+ CD4+ T-cells in Crohn’s Disease

Researchers

Presenter

  • Modos, D

Principal Investigators

  • Gul, L

  • Lo, J

  • Madgwick, M

  • Cozzetto, D

  • Lord, G

  • Korcsmaros, T

  • Powell, N

Medical Centers

  • Earlham Institute, Organisms and Ecosystems, Norwich, United Kingdom

  • Quadram Institute Bioscience, Gut Microbes and Health, Norwich, United Kingdom

  • Imperial College London, Department of Metabolism Digestion and Reproduction, London, United Kingdom

  • King's College, Centre for Inflammation Biology & Cancer Immunology, London, United Kingdom

  • Manchester University, Faculty of Biology- Medicine and Health, Manchester, United Kingdom

  • King’s College London, School of Immunology and Microbial Sciences, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • Cluster of Differentiation 4

  • Natural killer group 2D

Drug/Treatment

  • Interferon Gamma

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved